Saturday, October 31, 2026

Cocoa Futures Went Up By Over 24% In The Last 21 Sessions

ViaNews Editorial Team

November 6, 2023

Cocoa Futures Went Up By Over 24% In The Last 21 Sessions

(VIANEWS) - Cocoa (CC) has been up by 24.54% for the last 21 sessions. At 16:51 EST on Monday, 6 November, Cocoa (CC) is $3,913.00.

Volume

Today's last reported volume for Cocoa is 3665, 99.96% below its average volume of 11880170.29.

Volatility

Cocoa's last week, last month's, and last quarter's current intraday variation average was 1.09%, 0.75%, and 1.63%, respectively.

Cocoa's highest amplitude of average volatility was 1.17% (last week), 1.12% (last month), and 1.63% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Cocoa's commodity is considered to be oversold (<=20).

News about

  • According to DailyForex on Sunday, 5 November, "The West Texas Intermediate Crude Oil market continues to move on the latest headlines coming out of Gaza, and of course the idea of whether or not the economy will support higher prices. "
  • WTI crude oil: weekly forecast 5th November - 11th November - 05 November 2023. According to DailyForex on Sunday, 5 November, "If WTI Crude Oil begins to challenge the 80.000 USD level early this week it could be a sign the energy could slump lower, this while commodity companies search for equilibrium. ", "However, the trend lower the past month when September's highs are considered is troubling for speculative bulls.WTI Crude Oil Weekly Outlook:"
  • According to FXStreet on Monday, 6 November, "Furthermore, top exporters Saudi Arabia and Russia said they would stick to extra voluntary oil output cuts until the end of the year, which, in turn, acts as a tailwind for WTI Crude Oil prices.", "This, along with developments surrounding the Israel-Hamas conflict and the USD price dynamics, should contribute to producing some meaningful trading opportunities around Crude Oil prices."

More news about Cocoa (CC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com